Baxion
Screening
Tags
Alerts
Theme
Trevi Therapeutics, Inc.
TRVI
·
NASDAQ
·
$14.38
Share Price as of 11/2
·
$2B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/05/26
10-K
FY 2025
03/17/26
10-Q
Q3 ended 09/30/25
11/13/25
10-Q
Q2 ended 06/30/25
08/07/25
Disclosures
Filter
8-K
Current report
08/06/26
8-K
Current report
06/04/26
8-K
Current report
05/05/26
8-K
Current report
04/17/26
8-K
Current report
03/17/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
08/06/26
424B5
Prospectus supplement
04/17/26
424B5
Prospectus supplement
04/16/26
S-3ASR
Automatic shelf registration
11/13/25
S-8
Registration of securities for employees
08/07/25
Proxies
Filter
DEF 14A
Definitive proxy
04/21/26
DEFA14A
Additional proxy materials
04/21/26
PRE 14A
Preliminary proxy
04/10/26
DEF 14A
Definitive proxy
04/29/25
DEFA14A
Additional proxy materials
04/29/25
Ownership
Filter
Form 4
Insider transaction
09/17/26
144
Proposed sale of securities
09/15/26
SC 13G/A
Beneficial ownership (amended)
08/06/26
Form 4
Insider transaction
06/04/26
Form 4
Insider transaction
06/04/26
Other
Filter
ARS
Annual report to shareholders
04/21/26
ARS
Annual report to shareholders
04/29/25
ARS
Annual report to shareholders
04/29/24
EFFECT
Request for effectiveness
08/15/23
CORRESP
Correspondence with the SEC
08/14/23
Latest Filings
Filter
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Current report
08/06/26
S-8
Registration of securities for employees
08/06/26
8-K
Current report
06/04/26
10-Q
Q1 ended 03/31/26
05/05/26
Ownership
Filter
Form 4
Insider transaction
09/17/26
144
Proposed sale of securities
09/15/26
SC 13G/A
Beneficial ownership (amended)
08/06/26
Form 4
Insider transaction
06/04/26
Form 4
Insider transaction
06/04/26